Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload
Clinical trial NCT03255226 · COMPLETED
Trial details
- NCT number
- NCT03255226
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-07
- Primary completion
- 2021-07-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.